93 related articles for article (PubMed ID: 16686369)
1. Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse.
Zaher H; Khan AA; Palandra J; Brayman TG; Yu L; Ware JA
Mol Pharm; 2006; 3(1):55-61. PubMed ID: 16686369
[TBL] [Abstract][Full Text] [Related]
2. Maternal and Fetal Exposure to (-)-Δ
Chen X; Unadkat JD; Mao Q
Drug Metab Dispos; 2023 Mar; 51(3):269-275. PubMed ID: 36446608
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms.
Yang Z; Gao S; Wang J; Yin T; Teng Y; Wu B; You M; Jiang Z; Hu M
Drug Metab Dispos; 2011 Oct; 39(10):1866-72. PubMed ID: 21757611
[TBL] [Abstract][Full Text] [Related]
4. Assessment of contribution of BCRP to intestinal absorption of various drugs using portal-systemic blood concentration difference model in mice.
Kawahara I; Nishikawa S; Yamamoto A; Kono Y; Fujita T
Pharmacol Res Perspect; 2020 Feb; 8(1):e00544. PubMed ID: 31988753
[TBL] [Abstract][Full Text] [Related]
5. Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brain.
Strope JD; Peer CJ; Sissung TM; Hall OM; Huang PA; Harris EM; Gustafson KR; Henrich CJ; Sigano DM; Pauly GT; Schneider JP; Bates SE; Figg WD
Cancer Biol Ther; 2020; 21(3):223-230. PubMed ID: 31709896
[No Abstract] [Full Text] [Related]
6. Evaluation of Encequidar as An Intestinal P-gp and BCRP Specific Inhibitor to Assess the Role of Intestinal P-gp and BCRP in Drug-Drug Interactions.
Chu J; Panfen E; Wang L; Marino A; Chen XQ; Fancher RM; Landage R; Patil O; Desai SD; Shah D; Xue Y; Sinz M; Shen H
Pharm Res; 2023 Nov; 40(11):2567-2584. PubMed ID: 37523014
[TBL] [Abstract][Full Text] [Related]
7. Peripheral Hybrid CB
Zawatsky CN; Park JK; Abdalla J; Kunos G; Iyer MR; Cinar R
Front Endocrinol (Lausanne); 2021; 12():744857. PubMed ID: 34650521
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein (Mdr1a/1b) and breast cancer resistance protein (Bcrp) decrease the uptake of hydrophobic alkyl triphenylphosphonium cations by the brain.
Porteous CM; Menon DK; Aigbirhio FI; Smith RA; Murphy MP
Biochim Biophys Acta; 2013 Jun; 1830(6):3458-65. PubMed ID: 23454352
[TBL] [Abstract][Full Text] [Related]
9. Breast cancer resistance protein (Bcrp/Abcg2) is selectively modulated by lipopolysaccharide (LPS) in the mouse yolk sac.
Martinelli LM; Reginatto MW; Fontes KN; Andrade CBV; Monteiro VRS; Gomes HR; Almeida FRCL; Bloise FF; Matthews SG; Ortiga-Carvalho TM; Bloise E
Reprod Toxicol; 2020 Dec; 98():82-91. PubMed ID: 32916274
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba leaf extract suppresses intestinal human breast cancer resistance protein expression in mice: Correlation with gut microbiota.
Kim JK; Choi MS; Kim JY; Yu JS; Seo JI; Yoo HH; Kim DH
Biomed Pharmacother; 2021 Aug; 140():111712. PubMed ID: 34010745
[TBL] [Abstract][Full Text] [Related]
11. The Differential Absorption of a Series of P-Glycoprotein Substrates in Isolated Perfused Lungs from Mdr1a/1b Genetic Knockout Mice can be Attributed to Distinct Physico-Chemical Properties: an Insight into Predicting Transporter-Mediated, Pulmonary Specific Disposition.
Price DF; Luscombe CN; Eddershaw PJ; Edwards CD; Gumbleton M
Pharm Res; 2017 Dec; 34(12):2498-2516. PubMed ID: 28702798
[TBL] [Abstract][Full Text] [Related]
12. Dual Inhibition of P-gp and BCRP Improves Oral Topotecan Bioavailability in Rodents.
Lee J; Kang J; Kwon NY; Sivaraman A; Naik R; Jin SY; Oh AR; Shin JH; Na Y; Lee K; Lee HJ
Pharmaceutics; 2021 Apr; 13(4):. PubMed ID: 33921129
[TBL] [Abstract][Full Text] [Related]
13. Fetoplacental Disposition and Toxicity of Cadmium in Mice Lacking the Bcrp Transporter.
Kozlosky D; Doherty C; Buckley B; Goedken MJ; Miller RK; Huh DD; Barrett ES; Aleksunes LM
Toxicol Sci; 2023 Nov; 197(2):132-46. PubMed ID: 37941438
[TBL] [Abstract][Full Text] [Related]
14. The influence of the gut microbiota on the bioavailability of oral drugs.
Zhang X; Han Y; Huang W; Jin M; Gao Z
Acta Pharm Sin B; 2021 Jul; 11(7):1789-1812. PubMed ID: 34386321
[TBL] [Abstract][Full Text] [Related]
15.
Shen H; Huo R; Zhang Y; Wang L; Tong N; Chen W; Paris AJ; Mensah K; Chen M; Xue Y; Li W; Sinz M
J Pharmacol Exp Ther; 2024 Jan; ():. PubMed ID: 38296646
[TBL] [Abstract][Full Text] [Related]
16. Ivermectin inhibits ovine ABCG2-mediated in vitro transport of meloxicam and reduces its secretion into milk in sheep.
Blanco-Paniagua E; Garcia-Lino AM; Alvarez-Fernández L; Alvarez AI; Merino G
Res Vet Sci; 2022 Dec; 153():88-91. PubMed ID: 36327623
[TBL] [Abstract][Full Text] [Related]
17. Prediction of drug-drug interaction risk of P-glycoprotein substrate in drug discovery.
Kido Y; Nanchi I; Matsuzaki T; Watari R; Kiyohara H; Seki N; Okuda T
Drug Metab Pharmacokinet; 2024 Mar; 56():101008. PubMed ID: 38663183
[TBL] [Abstract][Full Text] [Related]
18. Herb-drug interaction: Effect of sinapic acid on the pharmacokinetics of dasatinib in rats.
Shahid M; Ahmad A; Raish M; Bin Jardan YA; Alkharfy KM; Ahad A; Abul Kalam M; Ahmad Ansari M; Iqbal M; Ali N; Al-Jenoobi FI
Saudi Pharm J; 2023 Nov; 31(11):101819. PubMed ID: 37860687
[TBL] [Abstract][Full Text] [Related]
19. ABCG2 Transports the Flukicide Nitroxynil and Affects Its Biodistribution and Secretion into Milk.
Álvarez-Fernández L; Blanco-Paniagua E; Merino G
Pharmaceutics; 2024 Apr; 16(4):. PubMed ID: 38675219
[TBL] [Abstract][Full Text] [Related]
20. Use of sulfasalazine for psoriasis: An evidence-based review.
Sood S; Bagit A; Maliyar K; Sachdeva M; Croitoru D; Yeung J
JAAD Int; 2024 Jun; 15():131-133. PubMed ID: 38545493
[No Abstract] [Full Text] [Related]
[Next] [New Search]
